1. Home
  2. NTLA vs KLG Comparison

NTLA vs KLG Comparison

Compare NTLA & KLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • KLG
  • Stock Information
  • Founded
  • NTLA 2014
  • KLG 2022
  • Country
  • NTLA United States
  • KLG United States
  • Employees
  • NTLA N/A
  • KLG N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • KLG Packaged Foods
  • Sector
  • NTLA Health Care
  • KLG Consumer Staples
  • Exchange
  • NTLA Nasdaq
  • KLG Nasdaq
  • Market Cap
  • NTLA 1.2B
  • KLG 1.4B
  • IPO Year
  • NTLA 2016
  • KLG N/A
  • Fundamental
  • Price
  • NTLA $10.90
  • KLG $23.05
  • Analyst Decision
  • NTLA Buy
  • KLG Hold
  • Analyst Count
  • NTLA 20
  • KLG 6
  • Target Price
  • NTLA $32.30
  • KLG $20.17
  • AVG Volume (30 Days)
  • NTLA 5.0M
  • KLG 946.6K
  • Earning Date
  • NTLA 08-07-2025
  • KLG 08-07-2025
  • Dividend Yield
  • NTLA N/A
  • KLG 2.86%
  • EPS Growth
  • NTLA N/A
  • KLG N/A
  • EPS
  • NTLA N/A
  • KLG 0.35
  • Revenue
  • NTLA $52,857,000.00
  • KLG $2,605,000,000.00
  • Revenue This Year
  • NTLA N/A
  • KLG N/A
  • Revenue Next Year
  • NTLA N/A
  • KLG N/A
  • P/E Ratio
  • NTLA N/A
  • KLG $66.68
  • Revenue Growth
  • NTLA 14.99
  • KLG N/A
  • 52 Week Low
  • NTLA $5.90
  • KLG $14.80
  • 52 Week High
  • NTLA $24.16
  • KLG $23.56
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 45.06
  • KLG 69.67
  • Support Level
  • NTLA $10.57
  • KLG $23.00
  • Resistance Level
  • NTLA $11.51
  • KLG $23.12
  • Average True Range (ATR)
  • NTLA 0.69
  • KLG 0.18
  • MACD
  • NTLA -0.26
  • KLG -0.25
  • Stochastic Oscillator
  • NTLA 10.44
  • KLG 42.45

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About KLG WK Kellogg Co

WK Kellogg is the second-largest cereal manufacturer in North America. Its cereal brands include Special K, Frosted Flakes, Raisin Bran, Froot Loops, Frosted Mini-Wheats, Kashi, Corn Flakes, Rice Krispies, Apple Jacks, and Bear Naked. The company was spun off from the former Kellogg business, now known as Kellanova, where the former firm's global snacks portfolio and international cereal brands are now housed. WK Kellogg, which began trading independently in October 2023, generates the bulk of its sales (about 88% of its fiscal 2024 base) in the US.

Share on Social Networks: